These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 6353059

  • 1. Amyloidosis: a familiar problem in the light of current pathogenetic developments.
    Kisilevsky R.
    Lab Invest; 1983 Oct; 49(4):381-90. PubMed ID: 6353059
    [No Abstract] [Full Text] [Related]

  • 2. Amyloid proteins, precursors, mediator, and enhancer.
    Cohen AS, Shirahama T, Sipe JD, Skinner M.
    Lab Invest; 1983 Jan; 48(1):1-4. PubMed ID: 6401828
    [No Abstract] [Full Text] [Related]

  • 3. Serum amyloid A and protein AA: molecular mechanisms of a transmissible amyloidosis.
    Westermark GT, Westermark P.
    FEBS Lett; 2009 Aug 20; 583(16):2685-90. PubMed ID: 19393650
    [Abstract] [Full Text] [Related]

  • 4. Are elevated serum amyloid A levels and amyloid-enhancing factor sufficient to induce inflammation-associated amyloid deposition?
    Kisilevsky R, Tan R, Subrahmanyan L, Snow A.
    Appl Pathol; 1984 Aug 20; 2(6):308-15. PubMed ID: 6400464
    [Abstract] [Full Text] [Related]

  • 5. [Pathogenesis of amyloidosis].
    Porwit-Ksiazek A.
    Pol Tyg Lek; 1980 Mar 17; 35(11):407-10. PubMed ID: 6770350
    [No Abstract] [Full Text] [Related]

  • 6. Further characterization of amyloid-enhancing factor.
    Axelrad MA, Kisilevsky R, Willmer J, Chen SJ, Skinner M.
    Lab Invest; 1982 Aug 17; 47(2):139-46. PubMed ID: 7109539
    [Abstract] [Full Text] [Related]

  • 7. Increased serum amyloid a levels reflect colitis severity and precede amyloid formation in IL-2 knockout mice.
    de Villiers WJ, Varilek GW, de Beer FC, Guo JT, Kindy MS.
    Cytokine; 2000 Sep 17; 12(9):1337-47. PubMed ID: 10975993
    [Abstract] [Full Text] [Related]

  • 8. [AL- and AA-amyloidosis (the status of the problem)].
    Kochubeĭ LN, Vinogradova OM, Serov VV, Vasil'eva NA, Tomas NIu.
    Klin Med (Mosk); 1988 Aug 17; 66(8):7-16. PubMed ID: 3057283
    [No Abstract] [Full Text] [Related]

  • 9. Characterization of splenic glycosaminoglycans accumulated in vivo in experimentally induced amyloid-susceptible and amyloid-resistant mice.
    Sugumaran G, Elliott-Bryant R, Phung N, Vitseva O, Kuberan B, Lech M.
    Scand J Immunol; 2004 Dec 17; 60(6):574-83. PubMed ID: 15584968
    [Abstract] [Full Text] [Related]

  • 10. Humoral and cellular aspects of amyloid disease: present status.
    Scheinberg MA, Wohlgethan JR, Cathcart ES.
    Prog Allergy; 1980 Dec 17; 27():250-76. PubMed ID: 6766217
    [No Abstract] [Full Text] [Related]

  • 11. The role of inflammatory cells in the pathogenesis of amyloidosis.
    Kisilevsky R, Axelrad M, Corbett W, Brunet S, Scott F.
    Lab Invest; 1977 Dec 17; 37(6):544-53. PubMed ID: 599900
    [Abstract] [Full Text] [Related]

  • 12. Successful treatment of multiple myeloma--associated amyloidosis by interferon-alpha, dimethyl sulfoxide, and VAD (vincristine, adriamycin, and dexamethasone).
    Ichida M, Imagawa S, Ohmine K, Komatsu N, Hatake K, Ozawa K, Miura Y.
    Int J Hematol; 2000 Dec 17; 72(4):491-3. PubMed ID: 11197218
    [Abstract] [Full Text] [Related]

  • 13. The cutaneous amyloidoses. Pathogenesis and therapy.
    Breathnach SM.
    Arch Dermatol; 1985 Apr 17; 121(4):470-5. PubMed ID: 3883907
    [No Abstract] [Full Text] [Related]

  • 14. [Current theories on the pathogenesis of amyloidosis].
    Kordecki H.
    Wiad Lek; 1982 Oct 15; 35(18):1171-6. PubMed ID: 6817524
    [No Abstract] [Full Text] [Related]

  • 15. [Amyloidosis: recent advances (author's transl)].
    Le Loët X, Ducastelle T, Deshayes P.
    Ann Med Interne (Paris); 1982 Oct 15; 133(3):152-9. PubMed ID: 7103300
    [Abstract] [Full Text] [Related]

  • 16. [Amyloidosis. II. Current pathogenetic and clinico-nosographic aspects].
    Lovisetto P, Frascisco M, Gilardi E, Marchi L, Mairano D.
    Minerva Med; 1980 Jun 23; 71(25):1801-13. PubMed ID: 6774298
    [Abstract] [Full Text] [Related]

  • 17. Fenofibrate inhibits reactive amyloidosis in mice.
    Murai T, Yamada T, Miida T, Arai K, Endo N, Hanyu T.
    Arthritis Rheum; 2002 Jun 23; 46(6):1683-8. PubMed ID: 12115201
    [Abstract] [Full Text] [Related]

  • 18. [The current procedures in the treatment of amyloidosis].
    Vinogradova OM, Kochubeĭ LN, Chegaeva TV.
    Ter Arkh; 1990 Jun 23; 62(6):139-45. PubMed ID: 2218913
    [No Abstract] [Full Text] [Related]

  • 19. [Improvements of gastrointestinal symptoms in a case of AA type amyloidosis by the combination therapy of prednisolone and dimethylsulfoxide].
    Imai Y, Himeno S, Shinomura Y, Kuroshima T, Minami Y, Tarui S, Isobe T, Tomita M.
    Nihon Naika Gakkai Zasshi; 1984 Sep 23; 73(9):1358-63. PubMed ID: 6520532
    [No Abstract] [Full Text] [Related]

  • 20. Association of apolipoprotein E with murine amyloid A protein amyloid.
    Kindy MS, King AR, Perry G, de Beer MC, de Beer FC.
    Lab Invest; 1995 Oct 23; 73(4):469-75. PubMed ID: 7474917
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.